Namrata Saroj, Chief Business Officer at OCULAR THERAPEUTIX, INC (OCUL), sold 51,730 shares at $10.74 ($556K) on 2025-11-05, disclosed to the SEC on 2025-11-07.
Scheduled sale ($556k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.74 | 25,865 | $278K | 50.0% |
| 2 | $10.74 | 25,865 | $278K | 50.0% |
| Total | $10.74 avg | 51,730 | $556K | 100% |